Welcome to
a visionary company at the forefront of transforming the healthcare landscape
Learn More
What we believe in
Revolutionising healthcare through technology and innovation

Who we are

Attison Global, a visionary company at the forefront of transforming the healthcare landscape. Our unwavering commitment to innovation and collaboration drives our pursuit of excellence in the ever-evolving realm of healthcare.

Learn More

What we do

Meet the dynamic duo behind Attison Global, a powerhouse team committed to driving innovation in healthcare. With their diverse backgrounds and complementary expertise, they are revolutionizing the industry by leveraging their unique skills and shared passion for transformative change.

Learn More
About Us

Company research

COVID-19 and Artificial Intelligence: the pandemic pacifier
December 2020

COVID-19 remains a threat to the entire world. In an attempt to curb its spread and facilitate its treatment, the technological tool that is Artificial Intelligence (AI) is being researched as a potential alternative to conventional methods.

Monoclonal Antibody Cocktail therapy for COVID-19: A Pharmacological innovation
December 2021

The novel SARS-CoV-2 infection has ripped through international health systems and protocols causing unprecedented mortality, morbidity and global trade deficits amounting to billions. Various monoclonal antibodies have been proposed for use in the treatment of COVID-19 infections

A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets
December 2020

The Coronavirus disease 2019 (COVID-19) pandemic is caused by rapidly spreading pathogenic virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that affects vast majority of population worldwide.

Pioneering the Future of Healthcare
Seeking investments that offer financial growth and a profound impact on the world? Look no further than Attison Global. We are a visionary company set to revolutionise the healthcare industry.